Selected Publications

• Larsen M E, Turner J, Farmer A, Neil A, and Tarassenko L (2010) Telemedicine-supported insulin optimisation in primary care. J Telemed Telecare.

• Nherera L, Calvert N W, Demott K, Humphries S E, Neil H AW, Minhas R, and Thorogood M (2010) Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia. Curr Med Res Opin, 26(3):529-36.

• de Galan Bastiaan E, Perkovic Vlado, Ninomiya Toshiharu, Pillai Avinesh, Patel Anushka, Cass Alan, Neal Bruce, Poulter Neil, Harrap Stephen, Mogensen Carl-Erik, Cooper Mark, Marre Michel, Williams Bryan, Hamet Pavel, Mancia Giuseppe, Woodward Mark, Glasziou Paul, Grobbee Diederick E, MacMahon Stephen, and Chalmers John (2009) Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol, 20(4):883-92.

• Farmer A J, Wade A N, French D P, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman R R, Mant D, Kinmonth A-L, and Neil H AW (2009) Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess, 13(15):iii-iv, ix-xi, 1-50.

• Hartweg Janine, Farmer Andrew J, Holman Rury R, and Neil Andrew (2009) Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol, 20(1):30-8.

Andrew Neil

Andrew is an Honorary Consultant Physician at the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), at the Churchill Hospital, and lead clinician for lipid services. His research has focused on the determinants of coronary heart disease and its prevention, particularly in relation to diabetes, dyslipidaemias and nutrition.

He is a member of the United Kingdom Prospective Diabetes Study (UKPDS) Executive Committee and a co-principal investigator of the Collaborative Atorvastatin Diabetes Study (CARDS). He directs the Simon Broome Familial Hyperlipidaemia Register, which is a UK multi-centre register of familial hyperlipidaemias that is assessing the genetic and metabolic determinants of premature vascular disease in familial hypercholesterolaemia.

See all publications.